MORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, was a key enrolling site for the primary completion of a Phase 3 rare disease ...

We preselected all newsletters you had before unsubscribing.

For decades, Africa's role in HIV research was framed as that of a peripheral "host, not driver". The just-concluded 2025 International Aids Society (IAS) conference in Kigali made it unmistakably ...